Analysis of MYRF gene variant in a fetus with Cardiac-urogenital syndrome.
10.3760/cma.j.cn511374-20220908-00612
- Author:
Hairui SUN
1
;
Hongjia ZHANG
;
Yihua HE
Author Information
1. School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China. heyihuaecho@hotmail.com.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
DNA Copy Number Variations;
Fetal Diseases;
Fetus/abnormalities*;
Heart Defects, Congenital/genetics*;
Mutation;
Transcription Factors/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(5):563-567
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the genetic basis for a fetus with Cardiac-urogenital syndrome (CUGS).
METHODS:A fetus with congenital heart disease identified at the Maternal Fetal Medical Center for Fetal Heart Disease, Beijing Anzhen Hospital Affiliated to Capital Medical University in January 2019 was selected as the study subject. Clinical data of the fetus was collected. Copy number variation sequencing (CNV-seq) and trio-whole exome sequencing (trio-WES) were carried out for the fetus and its parents. Candidate variants were verified by Sanger sequencing.
RESULTS:Detailed fetal echocardiographic examination had revealed hypoplastic aortic arch. The results of trio-WES revealed that the fetus has harbored a de novo splice variant of the MYRF gene (c.1792-2A>C), for which both parents were of the wild-type. Sanger sequencing confirmed the variant to be de novo. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was rated as likely pathogenic. CNV-seq has identified no chromosomal anomalies. And the fetus was diagnosed with Cardiac-urogenital syndrome.
CONCLUSION:The de novo splice variant of the MYRF gene probably underlay the abnormal phenotype in the fetus. Above finding has enriched the spectrum of MYRF gene variants.
